These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39177576)

  • 1. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis.
    Foersch S; Schmitt M; Litmeyer AS; Tschurtschenthaler M; Gress T; Bartsch DK; Pfarr N; Steiger K; Denkert C; Jesinghaus M
    J Pathol Clin Res; 2024 Sep; 10(5):e12394. PubMed ID: 39177576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
    Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K
    Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
    Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
    Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
    Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
    Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma?
    Celik SY; Çelik Öİ
    Indian J Pathol Microbiol; 2020; 63(3):418-422. PubMed ID: 32769331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
    Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
    Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].
    Xu KY; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):285-9. PubMed ID: 19434540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2.
    Huebner K; Erlenbach-Wuensch K; Prochazka J; Sheraj I; Hampel C; Mrazkova B; Michalcikova T; Tureckova J; Iatsiuk V; Weissmann A; Ferrazzi F; Kunze P; Nalli E; Sammer E; Gehring A; Cheema MM; Eckstein M; Paap EM; Soederberg A; Fischer C; Paul S; Mahadevan V; Ndreshkjana B; Meier MA; Muehlich S; Geppert CI; Merkel S; Grutzmann R; Roehe A; Banerjee S; Hartmann A; Sedlacek R; Schneider-Stock R
    Cell Mol Life Sci; 2022 Jul; 79(8):423. PubMed ID: 35838828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TROP2 expression as prognostic marker for gastric carcinoma.
    Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
    J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
    Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
    Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
    Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
    Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of TROP2 expression in patients with gallbladder cancer.
    Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM
    Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
    Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
    Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
    Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer.
    Jeon Y; Jo U; Hong J; Gong G; Lee HJ
    BMC Cancer; 2022 Sep; 22(1):1014. PubMed ID: 36153494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
    BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma.
    Zhang Y; Wang H; Overman M; Katz MH; Wang H
    Hum Pathol; 2023 Sep; 139():117-125. PubMed ID: 37516386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.
    Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M
    Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.